Treatments of generalized pustular psoriasis: A multicenter study in Japan

Journal of Dermatology

Volumn 26, Issue 3, 1999, Pages 141-149

  Ozawa, Akira ^a   Ohkido, Muneo ^a   Haruki, Yasuo ^a   Kobayashi, Hitoshi ^b   Ohkawara, Akira ^b   Ohno, Yoshiyuki ^c   Inaba, Yutaka ^d   Ogawa, Hideoki ^d  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

Cyclosporine; Generalized pustular psoriasis; Methotrexate; PUVA; Retinoid

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; METHOTREXATE; METHOXSALEN; NEW DRUG; RETINOID; TAZAROTENE;

ADULT; ARTICLE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG INDUCED DISEASE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ONSET AGE; ORAL DRUG ADMINISTRATION; PROGNOSIS; PSORIASIS; PUSTULAR PSORIASIS; PUVA; TONSILLECTOMY; TREATMENT OUTCOME;

EID: 0032940556     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1999.tb03444.x     Document Type: Article

References (31)

1. Camp RDR: Psoriasis, in Champion RH, Burton FJ, Ebling FJG (eds): Textbook of Dermatology, 5th ed, Blackwell Scientific Pub, Oxford, 1992, pp 1391-1457.
2. Zelickson BD, Muller SA: Generalized pustular psoriasis - A review of 63 cases, Arch Dermatol, 127: 1339-1345, 1991.
3. Ohkawara A, Yasuda H, Kobayashi H, et al: Generalized pustular psoriasis in Japan: Two distinct groups formed by differences in symptoms and genetic background, Acta Derm Venereol, 76: 68-71, 1996.
4. Ohkawara A, Kobayashi H, Kawashima T, Inaba Y, Kawamura T: Analysis of generalized pustular psoriasis in Japan - Treatments -, in Hashimoto I (ed): The Annual Report of the Research Committee of Rare Intractable Skin Diseases, the Ministry of Health and Welfare of Japan in 1995, the Reseach Committee of Rare and Intractable Skin Diseases (Chief: Hashimoto I), the Ministry of Health and Welfare of Japan, Tokyo, 1996, pp 157-161. (in Japanese)
5. Takagi H, Sato T, Inaba Y: Estimation errors with respect to the estimated number of patients in the nationwide epidemiological survery on intractable diseases, Jpn J Public Health, 35: 275-285, 1988.
6. Iizuka H: Psoriasis pustulosa and psoriasis arthropathica, in Hori Y, Niimura M (eds): Current Therapy in Skin Diseases '91-'98, Nankodo, Tokyo, 1997, pp 108-109. (in Japanese)
7. Georgala S, Rigopoulos D, Aroni K, Stratigos JT: Generalized pustular psoriasis precipitated by topical calcipotriol cream, Int J Dermatol, 33: 515-516, 1994.
8. Nomura K, Mizutani H, Inachi S, Shimizu M: Remission of pustular psoriasis after cholecystectomy: Role of focal infection in pustularization of psoriasis, J Dermatol, 22: 122-124, 1995.
9. Kuroda K, Kojima T, Tanabe E, Fujita M, Shinkai H: Pustular psoriasis precipitated by acetazoolamide, J Dermatol, 22: 784-787, 1995.
10. Tay YK, Tham SN: The profile and outcome of pustular psoriasis in Singapore: A report of 28 cases, Int J Dermatol, 36: 266-271, 1997.
11. Zelickson BD, Muller SA: Generalized pustular psoriasis in childhood - Report of thirteen cases, J Am Acad Dermatol, 24: 186-194, 1991.
12. Kumar B, Dhar S, Handa S, Kaur 1: Methotrexate in childhood psoriasis, Pediatr Dermatol, 11: 271-273, 1994.
13. Kalla G, Goyal AM: Juvenile generalized pustular psoriasis, Pediatr Dermatol, 13: 45-46, 1996.
14. Judge MR, MacDonald A, Black MM: Pustular psoriasis in childhood, Clin Exp Dermatol, 18: 97-99, 1993.
15. Faber EM, Nail L: Pustular psoriasis, Cutis, 51: 29-32, 1993.
16. Sackett DL, Rosenberg WM: The need for evidence-based medicine, JR Soc Med, 88: 620-624, 1995.
17. Wright S, Baker H: Generalized pustular psoriasis, in Roenigk HH, Maibach HI (eds): Psoriasis, 2nd ed, Marcel Dekker, New York, 1990, p 23.
18. Gollnick HP: Oral retinoids-efficacy and toxicity in psoriasis, Br J Dermatol, 135 (suppl 49): 6-17, 1996.
19. Boffa MJ, Chalmers RJ: Methotrexate for psoriasis, Clin Exp Dermatol, 21: 399-408, 1996.
20. Williams REA: Guidelines for management of patients with psoriasis, BMJ, 303: 829-835, 1991.
21. Nakayama J, Hori Y, Nakagawa H, et al: Comparison of two therapeutic regimens, continuous monotherapy and intermittent therapy, for long-term maintenance of remission of psoriasis with cyclosporine A, Eur J Dermatol, 6: 341-343, 1996.
22. Ozawa A, Sugai J, Ohkido M, et al: Continuous monotherapy versus intermittent long-term therapy with cyclosporin in psoriasis, Eur J Dermatol: 1999 (in press).
23. Greaves MW, Weinstein GD: Treatment of psoriasis, N Engl J Med, 332: 581-588, 1995.
24. Gottlieb SL, Heftler NS, Gilleaudeau P, et al: Short-contact anthralin treatment augments therapeutic efficary of cyclosporine in psoriasis: A clinical and pathological study, J Am Acad Dermatol, 33: 637-645, 1995.
25. Grossman RM, Thivolet J, Claudy A, et al: A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: Results of a multicenter placebo-controlled study, J Am Acad Dermatol, 31: 68-74, 1994.
26. Menter MA, See JA, Amend WJC, et al: Proceedings of the psoriasis combination and rotation therapy conference, J Am Acad Dermatol, 34: 315-321, 1996.
27. Petzelbauer P, Honigsmann J, Langer K, et al: Cyclosporine A in combination with phototherapy (PUVA) in the treatment of psoriasis, Br J Dermatol, 123: 641-647, 1990.
28. Millikan L (Guest editor): Neoral in psoriasis, Int J Dermatol, 36 (suppl 1), 1997.
29. Kragballe K (Guest editor): Vitamin D analogs in dermatology, J Am Acad Dermatol, 37, 1997.
30. Chandraratna RAS: Tazarotene-first of a new generation of receptor-selective retinoids, Br J Dermatol, 135 (suppl 49): 18-25, 1996.
31. Weinstein GD: Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis, Br J Dermatol, 135 (suppl 49): 32-36, 1996.